EP 1520021 A2 20050406 - ANTISENSE MODULATION OF LRH1 EXPRESSION
Title (en)
ANTISENSE MODULATION OF LRH1 EXPRESSION
Title (de)
ANTISENSE MODULIERUNG DER EXPRESSION VON LRH1
Title (fr)
MODULATION ANTISENS DE L'EXPRESSION DE LRH1
Publication
Application
Priority
- US 0320865 W 20030701
- US 39281302 P 20020701
Abstract (en)
[origin: WO2004003201A2] Antisense compounds, compositions and methods are provided for modulating the expression of Liver Related Homolog-1 (LRH1). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding LRH1. Methods of using these compounds for modulation of LRH1 expression and for treatment of diseases associated with expression of LRH1 are provided.
IPC 1-7
C12N 15/11; A61K 31/7115; A61K 31/712; A61K 31/7125; A61P 35/00; A61P 3/00; A61P 31/12; A61P 9/10
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/7088 (2006.01); A61K 48/00 (2006.01); A61P 1/16 (2006.01); A61P 3/00 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 9/10 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C12N 15/113 (2010.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 1/16 (2017.12); A61P 3/00 (2017.12); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 9/10 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C12N 15/1138 (2013.01); A61K 38/00 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3341 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01)
Citation (search report)
See references of WO 2004003201A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004003201 A2 20040108; WO 2004003201 A3 20040422; EP 1520021 A2 20050406; JP 2005532052 A 20051027
DOCDB simple family (application)
US 0320865 W 20030701; EP 03762317 A 20030701; JP 2004518213 A 20030701